A study of the Lund-Manchester research criteria for frontotemporal dementia: Clinical and single-photon emission CT correlations

Neurology

Volumn 48, Issue 4, 1997, Pages 937-942

  Miller, B L ^a,d   Ikonte, C ^a   Ponton, M ^a   Levy, M ^a   Boone, K ^a   Darby, A ^a   Berman, N ^b   Mena, I ^c   Cummings, J L ^a  

^a UCLA MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c CLÍNICA LAS CONDES   (Chile)

^d HARBOR UCLA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALZHEIMER DISEASE; ARTICLE; AWARENESS; BEHAVIOR DISORDER; CLINICAL ARTICLE; CONTROLLED STUDY; DEMENTIA; DISCRIMINANT ANALYSIS; FEEDING DISORDER; HUMAN; PERSEVERATION; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SPATIAL ORIENTATION; SPEECH DISORDER; STEREOTYPY;

EID: 0030897664     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/wnl.48.4.937     Document Type: Article

References (41)

1. Gustafson L, Brun A, Risberg J. Frontal lobe degeneration of non-Alzheimer type. II. Clinical picture and differential diagnosis. Arch Gerontol Geriatr 1987;6:209-223.
2. Neary D, Snowden JS, Northen B, Goulding PJ. Dementia of frontal lobe type. J Neurol Neurosurg Psychiatry 1988;51: 353-361.
3. Johanson A, Hagberg B. Psychometric characteristics in patients with frontal lobe degeneration of non-Alzheimer type. Arch Gerontol Geriatr 1989;8:129-137.
4. 99mTc-HM-PAO in the investigation of dementia. J Neurol Neurosurg Psychiatry 1987;50:1101-1109.
5. Brun A. Frontal lobe degeneration of non-Alzheimer type. I. Neuropathology. Arch Gerontol Geriatr 1987;6:193-208.
6. Brun A, Englund B, Gustafson L, et al. Clinical and neuropathological criteria for frontotemporal dementia. J Neurol Neurosurg Psychiatry 1994;57:416-418.
7. Read S, Miller BL, Mena I, et al. SPECT in dementia: clinical and pathological correlation. J Am Geriatr Soc 1995;43:1243-1247.
8. Pick A. On the relationship between aphasia and senile atrophy of the brain (1892). In: Rottenberg D, Hochberg FH, eds. Neurological classics in modern translation. New York: Hafner Press, 1977:35-40.
9. Kertesz A, Hudson L, Mackenzie IRA, Munoz DG. The pathology and nosology of primary progressive aphasia. Neurology 1994;44:2065-2072.
10. Neumann MA, Cohn R. Progressive subcortical gliosis, a rare form of presenile dementia. Brain 1967;90:405-418.
11. Knopman DS, Mastri AR, Frey WH, Sung JH, Ruston T. Dementia lacking distinctive histologic features: a common non-Alzheimer degenerative dementia. Neurology 1990;40:251-256.
12. Brun A. Frontal lobe dementia of the non-Alzheimer type revisited. Dementia 1993;4:126-131.
13. Miller BL, Cummings JL, Villanueva-Meyer J, et al. Frontal lobe degeneration: clinical, neuropsychological and SPECT characteristics. Neurology 1991;41:1374-1382.
14. Lynch T, Sano M, Marder KS, et al. Clinical characteristics of a family with chromosome 17-linked disinhibition-dementia-parkinsonism-amyotrophy complex. Neurology 1994;44:1878-1884.
15. Mesulam MM. Slowly progressive aphasia without generalized dementia. Ann Neurol 1982;11:592-598.
16. Morris JC, Cole M, Banker BQ, Wright D. Hereditary dysphasic dementia and the Pick-Alzheimer spectrum. Ann Neurol 1984;16:455-466.
17. Miller BL, Chang L, Mena I, Boone KB, Lesser I. Clinical and imaging features of right focal frontal lobe degenerations. Dementia 1993;4:204-213.
18. Snowden JS, Neary D, Mann MA, Goulding PJ, Testa HJ. Progressive language disorder due to lobar atrophy. Ann Neurol 1992;31:174-183.
19. Kirshner HS, Tanridag O, Thurman L, Whetsell WO. Progressive aphasia without dementia: two cases with focal spongiform degeneration. Ann Neurol 1987;22:527-532.
20. Wilhelmsen K, Lynch T, Pavlou E, Higgins M, Nygaard TG. Localization of disinhibition-dementia-parkinsonism-amyotrophy complex to 17q21-22. Am J Hum Genet 1994;55: 1150-1165.
21. Roses AD. Apolipoprotein E affects the rate of Alzheimer disease expression: beta-amyloid burden is a secondary consequence dependent on APOE genotype and duration of disease. J Neuropath Exp Neurol 1994;53:429-437.
22. Goate A, Chartier-Harlin MC, Mullan M, et al. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 1991;349:704.
23. Schellenberg GD, Bird TD, Wijsman EM, et al. Genetic evidence for a familial Alzheimer's disease locus on chromosome 14. Science 1992;258:668.
24. Rogaev E, Sherrington R, Liang Y, et al. Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene. Nature 1995;376:600-602.
25. Wilhelmsen K, Wszolek ZK, Currier RC, Lanska DJ. The clinical spectrums of chromosome 17q21-22-linked degenerative syndromes. Neurology 1996;46:A188.
26. Petersen RB, Tabaton M, Chen SG, et al. Familial progressive subcortical gliosis: presence of prions and linkage to chromosome 17. Neurology 1995;45:1062-1067.
27. Neary D, Snowden JS, Mann DMA. The clinical pathological correlates of lobar atrophy. Dementia 1993;4:154-159.
28. Chang L, Cornford M, Miller B, Itabashi H, Mena I. Ultrastructural abnormalities in a patient with frontal lobe dementia and motor neuron disease. Dementia 1995;6:1-8.
29. Jackson M, Lowe J. The new neuropathology of degenerative frontotemporal dementias. Acta Neuropathol 1996;91:127-134.
30. Risberg J, Passant U, Warkentin S, Gustafson L. Regional cerebral blood flow in frontal lobe dementia of non-Alzheimer type. Dementia 1993;14:186-187.
31. Jagust WJ, Reed BR, Seab JP, Kramer JH, Budinger TF. Clinical-physiological correlates of Alzheimer's disease and frontal lobe dementia. Am J Physiol Imag 1989;4:89-96.
32. Mendez MF, Selwood A, Mastri AR, Frey WH. Pick's disease versus Alzheimer's disease: a comparison of clinical characteristics. Neurology 1993;43:289-292.
33. Thal LJ. Assessment issues in clinical trials of tetrahydroaminoacridine and studies to alter decline in Alzheimer disease. Alz Dis Assoc Disord 1991;5:S37-S39.
34. Johnson K, Davis DR, Buonanno FS, Brady T, Rose TJ, Growdon JD. Comparison of magnetic resonance imaging and roentgen ray computerized tomography in dementia. Arch Neurol 1987;144:1075-1080.
35. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: a report of the NINCDS-ADRDA work-group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-944.
36. Cummings JL, Mega M, Gray K, Rosenberg-Thompson S, Carusi DA, Gornbein J. The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology 1994;44:2308-2314.
37. Morris JC, Heyman A, Mohs RC, et al. The Consortium to Establish a Registry for Alzheimer's disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease. Neurology 1989;39:1159-1165.
38. Folstein MF, Folstein SE, McHugh PR. "Mini-Mental State": a practical method for grading the cognitive state of patients for the clinician. J Psychiat Res 1975;12:189-198.
39. Miller BL, Darby AL, Swartz JR, Yener GG, Mena I. Dietary changes, compulsions and sexual behavior in fronto-temporal degeneration. Dementia 1995;6:195-199.
40. Lachin JM. Introduction to sample size determination and power analysis for clinical trials. Controlled Clin Trials 1981; 2:93-113.
41. Grossman M, D'Esposito M, Hughes E, et al. Language comprehension profiles in Alzheimer's disease, multi-infarct dementia, and frontotemporal degeneration. Neurology 1996;47:183-189.